DavidBrain

FDA Panel’s Surprising Vote on Peptides: What It Means for Patients and Providers

In late July 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) shocked many observers by narrowly recommending six peptides—BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon—for potential inclusion on the 503A Bulks List. This decision went against FDA scientists, who had advised rejecting all seven peptides under review. The only outright rejection was emideltide, also known […]

FDA Panel’s Surprising Vote on Peptides: What It Means for Patients and Providers Read More »

GLP-1 prescriptions

Direct-to-consumer GLP-1 prescriptions could make Walmart, Costco, and Amazon the biggest beneficiaries of the weight-loss boom.

As more employers stop covering GLP‑1 weight‑loss drugs like Wegovy and Zepbound, Americans are turning to direct‑to‑consumer (DTC) prescription programs. Big retailers, Walmart, Costco, CVS, and Amazon, are seizing this opportunity to expand their share of the pharmacy market. These prescriptions aren’t just one‑time sales; they create ongoing customer relationships. Every refill brings shoppers back

Direct-to-consumer GLP-1 prescriptions could make Walmart, Costco, and Amazon the biggest beneficiaries of the weight-loss boom. Read More »

Why Finding Medicines in Nigeria Is Still Hard And Why That Needs to Change

What You Should Know  Every day across Nigeria, people leave hospitals with prescriptions they cannot immediately fill, not because the medicines do not exist, but because no one knows exactly where they are. A patient may visit three pharmacies before finding a medication that should have been available from the beginning. Another may settle for

Why Finding Medicines in Nigeria Is Still Hard And Why That Needs to Change Read More »

Can Peptides Stop Hantavirus Pharmachain AI copyright Hantavirus [quantic69 / iStock / Getty Images Plus]

Could Peptides’ Superpower Emerge as a Game-Changer Against Deadly Hantavirus?

copyright Hantavirus [quantic69 / iStock / Getty Images Plus] Key Takeaways Hantavirus strikes fear into public health experts worldwide. This rodent-borne pathogen causes hantavirus pulmonary syndrome (HPS) in the Americas and hemorrhagic fever with renal syndrome (HFRS) elsewhere, diseases with fatality rates that can exceed 40% in severe cases. There are no approved specific treatments

Could Peptides’ Superpower Emerge as a Game-Changer Against Deadly Hantavirus? Read More »